Day: March 2, 2026

HBT Financial, Inc. Completes Merger with CNB Bank Shares, Inc.

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

BLOOMINGTON, Ill., March 02, 2026 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding company for Heartland Bank and Trust Company (“Heartland Bank”), today announced that it has completed its merger with CNB Bank Shares, Inc. (“CNB”), the holding company for CNB Bank & Trust, N.A. (“CNB Bank”). At the effective time of the Merger, CNB merged with a wholly-owned subsidiary of HBT, with CNB surviving as a wholly-owned subsidiary of HBT. Immediately thereafter, CNB merged (the “Merger”) with and into HBT Financial, with HBT Financial surviving the Merger. In addition, following the Merger, CNB Bank, CNB’s wholly-owned bank subsidiary, merged with and into Heartland Bank, with Heartland Bank continuing as the surviving bank. As of December 31, 2025, CNB had $1.8 billion in...

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

Written by Customer Service on March 2, 2026. Posted in Earnings Releases And Operating Results.

~ Held Type A meeting with FDA to discuss AMT-130 for Huntington’s disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of 2026 ~ ~ Completed enrollment of the first cohort in the Phase I/IIa study of AMT-260 in refractory mesial temporal lobe epilepsy, with additional clinical data expected in the first half of 2026 ~ ~ Presented updated Phase I/II data from AMT-191 in Fabry disease showing durable, dose-dependent increases in α-Gal A enzyme activity ~ ~ Cash, cash equivalents and current investment securities of approximately $622.5 million as of December 31, 2025 expected to fund operations into the second half of 2029 ~ ~ uniQure to host earnings call at 8:00 a.m. ET ~ LEXINGTON, Mass. and AMSTERDAM, March 02, 2026 (GLOBE NEWSWIRE) — uniQure N.V....

Hain Celestial Completes Sale of North American Snacks Business

Written by Customer Service on March 2, 2026. Posted in Public Companies.

Transaction sharpens focus on higher-margin core categoriesHain Celestial Completes Sale of North American Snacks BusinessProceeds from the transaction will be used to reduce debt, strengthening the company’s financial position and leverage profile.HOBOKEN, N.J., March 02, 2026 (GLOBE NEWSWIRE) — Hain Celestial Group (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today announced that it has completed the previously announced sale of its North American Snacks business, including Garden Veggie Snacks™, Terra® chips and Garden of Eatin’® snacks, to Snackruptors Inc., a Canadian, family-owned snacks manufacturer. Proceeds from the transaction will be used to reduce debt, strengthening the company’s financial position and...

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma’s Global Platform

Written by Customer Service on March 2, 2026. Posted in Public Companies.

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company’s royalty business in Asia. Ken joins Royalty Pharma from Morgan Stanley, where he was Head of Asia Pacific Healthcare Investment Banking. Asia-based biotechnology companies are now prolific creators of innovative therapeutics. In 2025, the out-licensing of Chinese medicines alone comprised over $130 billion of announced transaction value, up from approximately $14 billion in 2021, as multinational pharmaceutical companies increasingly recognized the value of this innovation. This momentum is expected to continue into 2026 and beyond, as modalities, therapeutic areas and deal structures out of...

GT Biopharma Reports Full Year 2025 Financial Results

Written by Customer Service on March 2, 2026. Posted in Public Companies.

Phase 1 trial evaluating GTB-3650 TriKE® continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express B7-H3 remains on track to initiate mid-2026 Unaudited proforma cash balance as of January 31, 2026 of approximately $9 million anticipated to provide sufficient cash runway through Q4 2026 SAN FRANCISCO, CALIFORNIA, March 02, 2026 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager TriKE® platform, today announced full year 2025 financial results for the period ended December 31, 2025. “2026 looks...

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Written by Customer Service on March 2, 2026. Posted in Public Companies.

Prof. Brown is a pioneer in Transcranial Magnetic Stimulation (TMS) and serves as current President of the Clinical TMS Society and Editor-in-Chief of the Transcranial Magnetic Stimulation journal. Extensive publication history in the science of neuroplasticity and its relationship to healing depression and PTSD. Unique background in charting a path for forward deployment of TMS with neuroplastic medication to treat depression and PTSD in military personnel, veterans, and first responders.WILMINGTON, Del., March 02, 2026 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has appointed Prof. Joshua C. Brown, MD, PhD, as its Chief Medical Innovation Officer. Prof. Brown, is a psychiatrist, neurologist, and neuroscientist who studies the underlying mechanisms...

Westhaven Appoints Senior Leaders in Indigenous, Community Relations and Permitting

Written by Customer Service on March 2, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) announces the appointments of Allison Rippin Armstrong as Vice President, Indigenous and Community Relations, and Pamela O’Hara as Vice President, Permitting and Government Affairs, effective April 1, 2026. Ken Armstrong, President and Chief Executive Officer of Westhaven, commented, “I am pleased to welcome Allison and Pamela to Westhaven at a defining stage for the Company. These appointments reflect the deliberate steps Westhaven and Dundee Corporation are taking to assemble the expertise and leadership needed to responsibly advance the Shovelnose gold project in southern British Columbia. Allison brings extensive experience working alongside Indigenous communities and navigating...

SPARC AI Appoints Matt McCrann as U.S. CEO

Written by Customer Service on March 2, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) — SPARC AI Inc. (the “Company”) (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0), developer of the Overwatch GPS-denied navigation and targeting platform, today announced the appointment of Matt McCrann as Chief Executive Officer of its U.S. subsidiary. McCrann will lead SPARC AI’s North American expansion, establishing the Company’s operational presence and deepening engagement with U.S. defense, federal, and allied government customers. The appointment advances SPARC AI’s strategy to scale in the world’s largest defense market amid growing demand for resilient navigation and targeting capability in contested environments. McCrann brings extensive experience building defense technology operations in the United States. He previously served as Chief Executive Officer of DroneShield’s...

Kaspi.kz 4Q & FY 2025 Financial Results

Written by Customer Service on March 2, 2026. Posted in Public Companies.

ALMATY, Kazakhstan, March 02, 2026 (GLOBE NEWSWIRE) — Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”) (Nasdaq:KSPI) today published its unaudited consolidated IFRS financial results for the quarter and fiscal year ended 31 December 2025 (“4Q & FY 2025” respectively). Letter from Mikhail Lomtadze: Two topics have dominated my conversations with investors over the last year: our progress in Türkiye and our approach to dividends. I want to address these and the other questions we hear most often, so that you better understand the context behind the decisions we’re taking. Both Türkiye and dividends connect to a single ambition: to build Kaspi.kz into a 100 million user company. We believe that every strategic decision we make – the launch of new products and services, investments in Türkiye, and dividend policy –...

CSG Enters the Hungarian Defence Industry. To Participate in the Delivery of Thousands of Military Vehicles; Investment Plans Also Include Integration of HIMARS Systems at Rába

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

The global industrial and technology group CSG will acquire a 49% stake in 4iG Space & Defence Technologies, thereby also indirectly becoming a 37% shareholder in Rába Automotive Holding Plc. Through this transaction, the Group confirms its ambition to become a long-term strategic partner of the Hungarian defence industry. The initial investments also include signed contracts for the production and delivery of thousands of military vehicles, as well as potential participation in the HIMARS programme for Hungary. The follow-on industrial projects further develop the previously announced partnership between CSG, 4iG and Rába Automotive Holding and create a foundation for long-term investment, technology transfer and the systematic localisation of production in Hungary. These steps will strengthen not only the Hungarian but also the...

Day: March 2, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals